About: Solid organ transplantation in the Coronavirus disease 2019 (COVID-19) Era: “The great bet” in the North Italy Transplant program (NITp) area

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Solid organ transplantation in the Coronavirus disease 2019 (COVID-19) Era: “The great bet” in the North Italy Transplant program (NITp) area Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Solid organ transplantation in the Coronavirus disease 2019 (COVID-19) Era: “The great bet” in the North Italy Transplant program (NITp) area
Creator	Buonocore, Ruggero Cannavò, Antonino Caporale, Vittoria Defeo, Maria Defeo, Tullia Fondazione, Kahan, Barry Maria, Passamonti, Serena Trunzo, Valentina
source	Elsevier; Medline; PMC
abstract	ABSTRACT INTRODUCTION solid organ transplantation may be considered challenging for waitlist patients during Coronavirus disease 2019 (COVID-19) pandemic. AIM the aim of this study was to investigate COVID-19 incidence and mortality in patients transplanted in the North Italy Transplant program (NITp) area during the outbreak. MATERIALS AND METHODS all consecutive patients transplanted from February 20 to April 3, 2020 (6 weeks) were included in our cohort and followed for at least 4 weeks. Survival analyses were performed. RESULTS one-hundred and twenty-four patients were transplanted with 12 (9.7%) hearts, 4 (3.2%) lungs, 39 (31.4%) livers, 67 (54%) kidneys, 2 (1.6%) combined kidney-pancreas. Recipients’ mean age was 51 years (SD±16.6) and 76/124 (61%) were male. Five (4%) developed COVID-19 after a mean of 13 days (SD±6.7) with a cumulative incidence of 4.0% (CI95%, 0.5-7.5). During the follow-up, 5/124 (4%) recipients died for an overall mortality of 4.3% (CI 95%, 0.6-8.0) of whom only one for COVID-19, for a COVID-19-related mortality of 0.8% (CI95%, 0-6.0). CONCLUSIONS this study showed a low COVID-19 incidence and related-mortality in patients transplanted during the COVID-19 era. Further studies with a longer follow-up are mandatory to confirm the safety of transplant procedures.
has issue date	2020-07-07(xsd:dateTime)
bibo:doi	10.1016/j.transproceed.2020.07.001
bibo:pmid	32723520
has license	els-covid
sha1sum (hex)	8cb9620dc346e30fa90558e5889c5cd2d46f5040
schema:url	https://doi.org/10.1016/j.transproceed.2020.07.001
resource representing a document's title	Solid organ transplantation in the Coronavirus disease 2019 (COVID-19) Era: “The great bet” in the North Italy Transplant program (NITp) area
has PubMed Central identifier	PMC7340017
has PubMed identifier	32723520
schema:publication	Transplant Proc
resource representing a document's body	covid:8cb9620dc346e30fa90558e5889c5cd2d46f5040#body_text
is schema:about of	named entity 'Transplant' named entity 'TITLE' named entity 'ABSTRACT' named entity 'SUBMITTED' named entity 'TRANSPLANTATION PROCEEDINGS' named entity 'SIGNED FORM' named entity 'COVID' named entity 'COVID-19' named entity '95%' named entity 'Lombardy' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'COVID-19' named entity 'infection' named entity 'COVID-19' named entity 'COVID' named entity 'infection' named entity 'Ph.D.' named entity 'cumulative incidence' named entity 'Ph.D.' named entity 'COVID' named entity 'COVID-19' named entity 'chest X-ray' named entity 'reverse transcription PCR' named entity 'M.D.' named entity '7.5' named entity 'COVID' named entity 'COVID-19' named entity 'bronchoalveolar lavage' named entity 'COVID' named entity 'RNA' named entity 'cumulative incidence' named entity 'COVID' named entity 'COVID-19' named entity 'follow-up' named entity 'transplanted organ' named entity '3.2%' named entity 'selection bias' named entity 'COVID' named entity 'Ph.D.' named entity 'Italy' named entity 'infection' named entity 'follow-up' named entity 'Armonk' named entity 'Kruskal-Wallis test' named entity 'quality of life' named entity 'nasopharyngeal swab' named entity 'PCR' named entity 't-test' named entity 'COVID' named entity 'demographical' named entity 'cohort study' named entity 'Ph.D.' named entity 'Kaplan-Meier' named entity 'M.D.' named entity 'SARS-CoV-2' named entity 'CT scan' named entity 'cumulative incidence' named entity 'COVID' named entity 'kidneys' named entity 'survival analysis' named entity 'ICU' named entity 'infection' named entity 'COVID' named entity 'Immunosuppressive' named entity 'Survival analyses' named entity 'follow-up' named entity 'infection' named entity 'COVID' named entity 'correlation' named entity 'COVID' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software